← FDA Drug Approvals (Drugs@FDA)
PEMETREXED
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON LTD · Approved 2018-05-04
Drug application
- FDA Application #
ANDA208927- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PEMETREXED
- Generic name
- Pemetrexed
- Active ingredients
- PEMETREXED
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- None (Tentative Approval)
- Sponsor
- BIOCON LTD
- First approval
- 2018-05-04
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown